DWDevon Watts

Devon Watts

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Devon Watts has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Joint Effects of Early Pandemic Containment Policies on Anxiety in the United States

    by Devon Watts, Pratik Nitin Khadse, Omid Ebrahimi, Justin Tubbs, James Lian, Lorenza Dall’AGlio, Daniel Fatori, Yu Zhou, Pedro Zuccolo, Mihael Cudic, et al.

    Importance: The impact of COVID-19 containment policies (e.g., physical distancing, school closures) on population anxiety has been debated and difficult to resolve. Objective: To estimate the joint effects of state-level COVID-19 containment policies on anxiety symptoms during the early pandemic. Design: Retrospective analysis of a prospective cohort with cross-sectional outcome assessment. Setting: All of Us Research Program, a U.S. national research cohort. Participants: 40,610 adult participants who completed the All of Us COPE survey in July 2020. Exposures: Seven state-level COVID-19 containment policies (school closures, workplace closures, cancellation of public events, restrictions on gatherings, public transport closures, stay-at-home requirements, and restrictions on internal movement) measured from March 22 to May 23, 2020, via the Oxford COVID-19 Government Response Tracker (OxCGRT). Main outcomes and measures: The primary outcome was anxiety symptoms (GAD-7) in July 2020. Using quantile g-computation, we classified policies as anxiety-increasing or anxiety-decreasing by the sign of their training-set contributions, then re-estimated joint effects in a holdout testing set. Results: Among participants (64% female; mean age: 57.8 years), 13.3% (n=5398) reported moderate-to-severe anxiety (GAD-7 score 10-21) in July 2020. The joint effect of all seven containment policies was not significant (β = 1.88, 95% CI: -0.51 to 4.28, p = 0.12). An anxiety-increasing joint effect from 4 policies (school, workplace, public events, internal movement; β = 2.98, 95% CI: 0.30 to 5.66, p = 0.03) and an anxiety-decreasing joint effect from 3 policies (gatherings, public transport, stay-at-home; β = -1.10, 95% CI: -1.75 to -0.44, p = 0.002) reached significance. Effects were largest in adults 18-44 (anxiety-increasing β = 8.93, 95% CI: 1.50 to 16.37, p = 0.02; anxiety-decreasing β = -2.81, 95% CI: -4.98 to -0.64, p = 0.01), with no significant effects in adults 45 and older. Conclusions and Relevance: Modeling seven containment policies jointly showed no net anxiety effect, a result that masked opposing-direction effects. Partitioning by effect direction revealed significant joint effects exceeding single-policy estimates, with young-adult point estimates above the 4-point GAD-7 minimal clinically important difference (MCID) though lower CI bounds fell below it. These findings may inform the use of containment policies in future pandemics, given their differing association with population anxiety.

  • Open Access

    Association of Genetic Liability to Psychiatric Disorders with Peripheral Metabolic Dysregulation

    by Juan F. De la Hoz, Younga Heather Lee, Justin D. Tubbs, William Meyerson, Mihael Cudic, Devon Watts, Yen-Chen Anne Feng, Yulu Chen, Jessica Lasky-Su, Tian Ge, et al.

    Importance: Individuals with psychiatric disorders face elevated cardiometabolic risk which is linked to increased mortality. The extent to which this reflects shared pathogenesis or the downstream effects of illness and treatment remains poorly understood. Objective: To characterize the direct pleiotropic effects of psychiatric genetic liability on circulating metabolites and aggregate cardiometabolic risk, independent of psychiatric diagnosis and psychotropic medication use. Design, Setting and Participants: Cross-sectional analysis of Mass General Brigham Biobank participants with metabolomic profiling, genomic data, and linked electronic health records. Exposures: Genetic liability to nine psychiatric disorders quantified using polygenic risk scores (PRS): attention deficit/hyperactivity disorder (ADHD), anorexia nervosa (ANO), anxiety disorder (ANX), autism spectrum disorder (ASD), bipolar disorder (BD), major depressive disorder (MDD), PTSD, schizophrenia (SCZ), and substance use disorder (SUD). Main Outcomes and Measures: 249 circulating metabolites and four metabolomic risk scores (MRS) for type 2 diabetes, myocardial infarction, ischemic stroke, and vascular dementia. PRS-metabolite associations were estimated using nested models adjusting for lifetime psychiatric diagnosis and psychotropic medication use. Results: Across 25,290 participants, we identified 604 significant PRS-metabolite associations (Bonferroni p< 1.36 × 10 -4 ), of which 89% persisted after adjustment for lifetime diagnosis and medication use, suggesting that the direct genetic effects on metabolism are largely independent of illness or treatment. PRS for MDD, PTSD, and ADHD showed the most extensive dysregulation, with a transdiagnostic pattern of elevated lipids and systemic inflammation, specifically triglycerides (β = 0.04 to 0.05, all p< 4.4 ×10 -13 ) and glycoprotein acetyls (β = 0.05, all p< 2.2 ×10 -16 ). Notably, PRS for SCZ and BD showed minimal metabolite dysregulation despite having the strongest association with their target diagnoses. PRS for MDD, PTSD, ADHD, and SUD were associated with increased MRS across cardiometabolic conditions (β = 0.03 to 0.08, all p< 2.1 ×10 -4 ). Sensitivity analyses controlling for BMI or excluding participants without any psychiatric history (N: 21,305 and 11,150, respectively) showed a similar pattern. Conclusions and Relevance: Psychiatric genetic liability is associated with systemic metabolic dysregulation independent of illness onset or treatment, supporting a partially pleiotropic basis for psychiatric-cardiometabolic comorbidity. Key findings: Question: Does genetic liability to psychiatric disorders influence peripheral metabolism independent of psychiatric diagnosis and treatment? Findings: In 25,290 participants, polygenic scores for major depressive disorder, posttraumatic stress disorder, and attention deficit hyperactivity disorder showed widespread associations with metabolic dysregulation, such as elevated triglycerides and systemic inflammation, which persisted after adjusting for diagnosis and medication use. Polygenic scores for schizophrenia and bipolar disorder showed minimal metabolite associations despite their well-established cardiometabolic burden. Meaning: Shared genetic pathways partially underlie psychiatric and cardiometabolic comorbidity, implicating transdiagnostic biomarker profiles.

  • Open Access

    Would Lifting Versus Maintaining COVID-19 Containment Policies Have Reduced Psychological Distress in the US?

    by Mihael Cudic, Juan F de la Hoz, Lorenza Dall’Aglio, Justin D. Tubbs, Omid V. Ebrahimi, Emily Madsen, Daniel Fatori, Pedro F Zuccolo, James Lian, Dia Kabir, et al.

    Background: Both the COVID-19 pandemic and containment policies caused widespread psychological distress, yet their independent effects remain unclear. Disentangling these effects could inform future responses that balance physical and mental health. This study sought to estimate the effect of lifting versus maintaining containment policies on psychological distress, independent of pandemic severity. Methods: We conducted a state-level longitudinal analysis using the Behavioral Risk Factor Surveillance System (BRFSS), a representative survey of US adults, restricted to the pandemic period preceding widespread vaccine availability (April 2020 to April 2021). The exposure was lifting versus maintaining containment policies (school closures, workplace closures, event cancellations, and full lockdown) from the Oxford COVID-19 Government Response Tracker. Exposure was measured during periods of low (14 days) pandemic severity. The primary outcome was prevalence of psychological distress, derived from a BRFSS survey item corresponding to a PHQ-4 score ≥6. Findings: Three causal inference approaches yielded consistent evidence of transient policy-lifting effects: (1) synthetic control analysis of Maine showed a temporary 5.5 percentage-point reduction in psychological distress lasting three months before returning to counterfactual levels; (2) within-state fixed effects found immediately after lifting full lockdown, distress decreased by 5.68 [-8.67, −2.69] percentage points, declining by 30 days (−3.24 [-6.88, 0.39]) and negligible at 60 days (−0.94 [-3.77, 1.89]); (3) target trial emulation detected no significant effects from lifting versus maintaining policies for 90 days. Interpretation: Lifting containment policies in the first year of the pandemic produced immediate but transient reductions in psychological distress. These results suggest that extended containment policies were unlikely to account for persistent increases in distress during this period.


  • Open Access

    Mapping heterogeneity in the neuroanatomical correlates of depression

    by Devon Watts, Travis Triplett Mallard, Lorenza Dall’ Aglio, Evan Giangrande, Chris Kennedy, Na Cai, Karmel W Choi, Tian Ge, Jordan W. Smoller

    Major depressive disorder (MDD) affects millions worldwide, yet its neurobiological underpinnings remain elusive. Neuroimaging studies have yielded inconsistent results, hindered by small sample sizes and heterogeneous depression definitions. We sought to address these limitations by leveraging the UK Biobank’s extensive neuroimaging data (n=30,122) to investigate how depression phenotyping depth influences neuroanatomic profiles of MDD. We examined 256 brain structural features, obtained from T1- and diffusion-weighted brain imaging, and nine depression phenotypes, ranging from self-reported symptoms (shallow definitions) to clinical diagnoses (deep). Multivariable logistic regression, machine learning classifiers, and feature transfer approaches were used to explore correlational patterns, predictive accuracy and the transferability of important features across depression definitions. For white matter microstructure, we observed widespread fractional anisotropy decreases and mean diffusivity increases. In contrast, cortical thickness and surface area were less consistently associated across depression definitions, and demonstrated weaker associations. Machine learning classifiers showed varying performance in distinguishing depression cases from controls, with shallow phenotypes achieving similar discriminative performance (AUC=0.807) and slightly higher positive predictive value (PPV=0.655) compared to deep phenotypes (AUC=0.831, PPV=0.456), when sensitivity was standardized at 80%. However, when shallow phenotypes were downsampled to match deep phenotype case/control ratios, performance degraded substantially (AUC=0.690). Together, these results suggest that while core white-matter alterations are shared across phenotyping strategies, shallow phenotypes require approximately twice the sample size of deep phenotypes to achieve comparable classification performance, underscoring the fundamental power-specificity tradeoff in psychiatric neuroimaging research.

  • Open Access

    Leveraging Feature Transfer to Predict Medication Resistance and Secondary-Clinical Outcomes in Psychotic Disorders in Forensic Settings

    by Devon Watts, Heather Moulden, Mini Mamak, Ives Passos, Gary Chaimowitz

    Medication resistance in psychotic disorders represents a critical challenge in forensic psychiatry, where up to 50% of patients show poor treatment response, leading to increased risk of relapse, violence, and rehospitalization. Feature Transfer, a novel machine learning framework based on rank aggregated feature selection, transfers predictive features identified for one outcome to related outcomes while maintaining clinical interpretability, a critical advantage over conventional transfer learning approaches that obscure feature level insights by transferring complex model parameters. Applied to psychotic disorders, this methodology identified key predictors for medication resistance and assessed their transferability to related clinical outcomes. Analyzing data from 893 patients across 11 forensic psychiatric institutions, we compared Feature Transfer models (using the top 25 features discriminating medication resistance from responders) with full feature models (95 features) for predicting clinical relapse, treatment non adherence, and escape behaviors. In the broader psychotic disorders sample, Feature Transfer achieved statistically equivalent performance to full feature models for clinical relapse and treatment non adherence (F1 score differences with confidence intervals overlapping zero), though performed less effectively for escape behaviors (AUC: 0.736 vs 0.838). In schizophrenia patients (n=634), Feature Transfer showed statistically significant improvement in F1 score for clinical relapse prediction compared to full feature models (difference: 0.119, 95% CI: 0.025 to 0.213), with notably higher sensitivity (0.912 vs 0.802) while maintaining comparable discriminative ability (AUC: 0.912 vs 0.925, difference not statistically significant). Treatment history features, particularly previous medication unresponsiveness and duration of clinical care, maintained high predictive importance across multiple clinical outcomes (relapse, non adherence, and escape behaviors), suggesting they represent fundamental risk indicators regardless of the specific outcome being predicted. While our retrospective design limits causal inference and relies on historical indicators as proxies for secondary outcomes (relapse and escape behaviors), the demonstrated utility of medication resistance features across different clinical outcomes reveals potential shared risk dimensions in psychotic disorders, particularly for relapse prediction in schizophrenia. Feature Transfer offers a transparent approach for identifying common predictive factors that could advance personalized intervention strategies in complex psychiatric populations.

  • Open Access

    Validating the efficacy and value proposition of Mental Fitness Vocal Biomarkers in a psychiatric population: prospective cohort study

    by Erik Larsen, Olivia Murton, Xinyu Song, Dale Joachim, Devon Watts, Flavio Kapczinski, Lindsey Venesky, Gerald Hurowitz

    This study represents a practical advancement in the application of vocal biomarkers for mental health tracking in real-world settings. Through a prospective cohort study involving 104 participants from an outpatient psychiatric population, we introduced a novel “Mental Fitness Vocal Biomarker” (MFVB) score, derived from eight preselected vocal features supported by literature review. Our findings demonstrate the MFVB’s efficacy in objectively stratifying individuals based on risk for elevated mental health symptom severity using the M3 Checklist for transdiagnostic assessment (depression, anxiety, post-traumatic stress disorder, and bipolar) as reference standard. Continuous observation over time significantly improves efficacy, yielding a risk ratio of 1.53 (1.09-2.14, p=0.0138) for single 30-second voice samples to 2.00 (1.21-3.30, p=0.0068) for 2-week aggregations, depending on MFVB score. Notably, in the highly engaged subgroup (5-6 MFVB uses per week, 38% of participants), a risk ratio of 8.50 (2.31-31.25, p=0.0013) was observed, underscoring the utility of frequent and continuous observation. Participant feedback confirmed the user-friendliness of the application and perceived benefits, highlighting the MFVB’s potential as a cost-effective, scalable, and privacy-preserving adjunct to traditional psychiatric assessments. These results establish that vocal biomarkers are a promising tool for objective mental health tracking in real-world conditions, offering personalized insights into users’ mental well-being as they engage with clinical therapy or other beneficial activities that are associated with improved mental health risks and outcomes.

  • Premorbid intelligence quotient and school failure as risk markers for bipolar disorder and major depressive disorder

    by Francisco Diego Rabelo-Da-Ponte, Lauro Estivalete Marchionatti, Devon Watts, Thiago Henrique Roza, Silvia Amoretti, Fernando C. Barros, Fernando C. Wehrmeister, Helen Gonçalves, Ana Maria B Menezes, Maurício Kunz, et al.


  • The HARM models: Predicting longitudinal physical aggression in patients with schizophrenia at an individual level

    by Devon Watts, Mini Mamak, Heather Moulden, Casey Upfold, Taiane de Azevedo Cardoso, Flavio Kapczinski, Gary Chaimowitz


  • Prenatal and perinatal risk factors for bipolar disorder: A systematic review and meta-analysis

    by Augusto Ossamu Shintani, Francisco Diego Rabelo-Da-Ponte, Lauro Estivalete Marchionatti, Devon Watts, Fernando Ferreira de Souza, Cristiane dos Santos Machado, Rafaela Fernandes Pulice, Giovanna Maiolli Signori, Rafael Rocha Luzini, Márcia Kauer-Sant'ANna, et al.


  • Open Access

    Predicting criminal and violent outcomes in psychiatry: a meta-analysis of diagnostic accuracy

    by Devon Watts, Taiane de Azevedo Cardoso, Diego Librenza-Garcia, Pedro Ballester, Ives Cavalcante Passos, Felix H. P. Kessler, Jim Reilly, Gary Chaimowitz, Flavio Kapczinski

    Although reducing criminal outcomes in individuals with mental illness have long been a priority for governments worldwide, there is still a lack of objective and highly accurate tools that can predict these events at an individual level. Predictive machine learning models may provide a unique opportunity to identify those at the highest risk of criminal activity and facilitate personalized rehabilitation strategies. Therefore, this systematic review and meta-analysis aims to describe the diagnostic accuracy of studies using machine learning techniques to predict criminal and violent outcomes in psychiatry. We performed meta-analyses using the mada, meta, and dmetatools packages in R to predict criminal and violent outcomes in psychiatric patients (n = 2428) (Registration Number: CRD42019127169) by searching PubMed, Scopus, and Web of Science for articles published in any language up to April 2022. Twenty studies were included in the systematic review. Overall, studies used single-nucleotide polymorphisms, text analysis, psychometric scales, hospital records, and resting-state regional cerebral blood flow to build predictive models. Of the studies described in the systematic review, nine were included in the present meta-analysis. The area under the curve (AUC) for predicting violent and criminal outcomes in psychiatry was 0.816 (95% Confidence Interval (CI): 70.57–88.15), with a partial AUC of 0.773, and average sensitivity of 73.33% (95% CI: 64.09–79.63), and average specificity of 72.90% (95% CI: 63.98–79.66), respectively. Furthermore, the pooled accuracy across models was 71.45% (95% CI: 60.88–83.86), with a tau squared (τ2) of 0.0424 (95% CI: 0.0184–0.1553). Based on available evidence, we suggest that prospective models include evidence-based risk factors identified in prior actuarial models. Moreover, there is a need for a greater emphasis on identifying biological features and incorporating novel variables which have not been explored in prior literature. Furthermore, available models remain preliminary, and prospective validation with independent datasets, and across cultures, will be required prior to clinical implementation. Nonetheless, predictive machine learning models hold promise in providing clinicians and researchers with actionable tools to improve how we prevent, detect, or intervene in relevant crime and violent-related outcomes in psychiatry.